What's new in general surgery: Endocrine surgery

Journal of the American College of Surgeons

Volumn 201, Issue 5, 2005, Pages 746-753

  Duh, Quan Yang ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; B RAF KINASE; COMPLEMENTARY DNA; CYCLIN D2; MITOGEN ACTIVATED PROTEIN KINASE; OCTREOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN P53; PROTEIN PATCHED; PROTEIN RET; PROTEIN SERINE THREONINE KINASE; RAS PROTEIN; SOMATOSTATIN DERIVATIVE; TRANSCRIPTION FACTOR PAX8;

AMINO ACID SUBSTITUTION; ANAPLASTIC CARCINOMA; ASPIRATION BIOPSY; BONE DENSITY; CANCER GROWTH; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CHERNOBYL ACCIDENT; CHROMOSOME TRANSLOCATION; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DNA MICROARRAY; DNA STRAND BREAKAGE; DRUG EFFICACY; ENDOCRINE SURGERY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENERAL SURGERY; GOITER; GRAVES DISEASE; HEMOSTASIS; HUMAN; HYPERPARATHYROIDISM; LYMPHADENOPATHY; MELANOMA; MINIMALLY INVASIVE SURGERY; MITOSIS; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; OPERATION DURATION; PARATHYROIDECTOMY; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RECURRENT LARYNGEAL NERVE PALSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SHORT FORM 36; SIGNAL TRANSDUCTION; THYROID CANCER; THYROIDECTOMY; TREATMENT INDICATION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

EID: 27544470901     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2005.07.007     Document Type: Article

References (50)

1. M.N. Nikiforova, E.T. Kimura, M. Gandhi BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas J Clin Endocrinol Metab 88 2003 5399 5404
2. E.T. Kimura, M.N. Nikiforova, Z. Zhu High prevalence of BRAF mutations in thyroid cancer genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma Cancer Res 63 2003 1454 1457
3. M. Xing BRAF mutation in thyroid cancer Endocr Relat Cancer 12 2005 245 262
4. J.A. Fagin Editorial Challenging dogma in thyroid cancer molecular genetics - role of RET/PTC and BRAF in tumor initiation J Clin Endocrinol Metab 89 2004 4264 4266
5. A. Kumagai, H. Namba, V.A. Saenko Comment low frequency of BRAFT1796A mutations in childhood thyroid carcinomas J Clin Endocrinol Metab 89 2004 4280 4284
6. J. Lima, V. Trovisco, P. Soares BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas J Clin Endocrinol Metab 89 2004 4267 4271
7. C.M. Caudill, Z. Zhu, R. Ciampi Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to γ-radiation a model of carcinogenic chromosomal rearrangement induced by ionizing radiation J Clin Endocrinol Metab 90 2005 2364 2369
8. M.N. Nikiforova, R.A. Lynch, P.W. Biddinger RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors evidence for distinct molecular pathways in thyroid follicular carcinoma J Clin Endocrinol Metab 88 2003 2318 2326
9. J.W. Park, R. Zarnegar, H. Kanauchi Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines Thyroid 15 2005 222 231
10. R. Sorrentino, S. Libertini, P.L. Pallante Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation J Clin Endocrinol Metab 90 2005 928 935
11. Y.E. Nikiforov Editorial Anaplastic carcinoma of the thyroid-will Aurora B light a path for treatment? J Clin Endocrinol Metab 90 2005 1243 1245
12. E.A. Harrington, D. Bebbington, J. Moore VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo Nat Med 10 2004 262 267
13. D.J. Finley, B. Zhu, C.B. Barden, T.J. Fahey 3rd Discrimination of benign and malignant thyroid nodules by molecular profiling Ann Surg 240 2004 425 436 discussion 436-437
14. D.J. Finley, N. Arora, B. Zhu molecular profiling distinguishes papillary carcinoma from benign thyroid nodules J Clin Endocrinol Metab 89 2004 3214 3223
15. F. Weber, L. Shen, M.A. Aldred Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination J Clin Endocrinol Metab 90 2005 2512 2521
16. D.J. Finley, B. Zhu, T.J. Fahey 3rd Molecular analysis of Hürthle cell neoplasms by gene profiling Surgery 136 2004 1160 1168
17. M. Zou, K.S. Famulski, R.S. Parhar Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis identification of S100A4 (mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma J Clin Endocrinol Metab 89 2004 6146 6154
18. P. Chinnappa, L. Taguba, R. Arciaga Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease sensitive and specific markers for thyroid cancer J Clin Endocrinol Metab 89 2004 3705 3709
19. K. Wagner, R. Arciaga, A. Siperstein Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology diagnostic synergy for detecting thyroid cancer J Clin Endocrinol Metab 90 2005 1921 1924
20. T. Sato, M. Harao, S. Nakano Circulating tumor cells detected by reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA distinguishing follicular thyroid carcinoma from adenoma Surgery 137 2005 552 558
21. G. Salvatore, R. Giannini, P. Faviana Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma J Clin Endocrinol Metab 89 2004 5175 5180
22. E. Saggiorato, R. De Pompa, M. Volante Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers a proposal for clinical application Endocr Relat Cancer 12 2005 305 317
23. M.A. Kouvaraki, J.E. Lee, S.E. Shapiro Preventable reoperations for persistent and recurrent papillary thyroid carcinoma Surgery 136 2004 1183 1191
24. M. Torlontano, M. Attard, U. Crocetti Follow-up of low risk patients with papillary thyroid cancer role of neck ultrasonography in detecting lymph node metastases J Clin Endocrinol Metab 89 2004 3402 3407
25. F.Y. Chiang, L.F. Wang, Y.F. Huang Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve Surgery 137 2005 342 347
26. H. Dralle, C. Sekulla, J. Haerting Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery Surgery 136 2004 1310 1322
27. D.E. Yarbrough, G.B. Thompson, J.L. Kasperbauer Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery Surgery 136 2004 1107 1115
28. L.M. Hurtado-Lopez, M.I. Pacheco-Alvarez, L. Montes-Castillo Mde, F.R. Zaldivar-Ramirez Importance of the intraoperative identification of the external branch of the superior laryngeal nerve during thyroidectomy electromyographic evaluation Thyroid 15 2005 449 454
29. C. Cordon, R. Fajardo, J. Ramirez, M.F. Herrera A randomized, prospective, parallel group study comparing the Harmonic Scalpel to electrocautery in thyroidectomy Surgery 137 2005 337 341
30. W.T. Shen, M.A. Baumbusch, E. Kebebew, Q.Y. Duh Use of the electrothermal vessel sealing system versus standard vessel ligation in thyroidectomy Asian J Surg 28 2005 86 89
31. R. Bellantone, C.P. Lombardi, M. Boscherini Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area results of a multivariate analysis Surgery 136 2004 1247 1251
32. R. Elisei, V. Bottici, F. Luchetti Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer experience in 10,864 patients with nodular thyroid disorders J Clin Endocrinol Metab 89 2004 163 168
33. J.L. Wemeau, P. Caron, A. Beckers Octreotide (long-acting release formulation) treatment in patients with Graves' orbitopathy clinical results of a four-month, randomized, placebo-controlled, double-blind study J Clin Endocrinol Metab 90 2005 841 848
34. A.J. Dickinson, B. Vaidya, M. Miller Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy J Clin Endocrinol Metab 89 2004 5910 5915
35. N.D. Perrier Asymptomatic hyperparathyroidism a medical misnomer? Surgery 137 2005 127 131
36. M.S. Eigelberger, W.K. Cheah, P.H. Ituarte The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism are they too limited? Ann Surg 239 2004 528 535
37. D.S. Rao, E.R. Phillips, G.W. Divine, G.B. Talpos Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism J Clin Endocrinol Metab 89 2004 5415 5422
38. E.G. Almqvist, C. Becker, A.G. Bondeson Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism a prospective and randomized study Surgery 136 2004 1281 1288
39. A.A. Khan, J.P. Bilezikian, A.W. Kung Alendronate in primary hyperparathyroidism a double-blind, randomized, placebo-controlled trial J Clin Endocrinol Metab 89 2004 3319 3325
40. I.L. Nilsson, C. Wadsten, L. Brandt Mortality in sporadic primary hyperparathyroidism nationwide cohort study of multiple parathyroid gland disease Surgery 136 2004 981 987
41. K. Friedman, H. Somervell, P. Patel Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism Surgery 136 2004 1199 1204
42. R.E. Royal, E.S. Delpassand, S.E. Shapiro Improving the yield of preoperative parathyroid localization technetium Tc 99m-sestamibi imaging after thyroid suppression Surgery 132 2002 968 974 discussion 974-975
43. A. Siperstein, E. Berber, R. Mackey Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism Surgery 136 2004 872 880
44. S.L. Sugg, E.A. Krzywda, M.J. Demeure, S.D. Wilson Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy Surgery 136 2004 1303 1309
45. K.J. Weber, S. Misra, J.K. Lee Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success Surgery 136 2004 1154 1159
46. K. Kaczirek, P. Riss, G. Wunderer Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism Surgery 137 2005 431 435
47. K. Yao, F.R. Singer, S.I. Roth Weight of normal parathyroid glands in patients with parathyroid adenomas J Clin Endocrinol Metab 89 2004 3208 3213
48. L. Delbridge, R. Mun, M. Wilkinson, A. Conigrave Surgery for hyperparathyroidism does function or size matter most? Surgery 138 2005 (in press).
49. H. Yamashita, P. Gao, T. Cantor Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism Surgery 135 2004 149 156
50. C.P. Lombardi, M. Raffaelli, P. Princi Early prediction of postthyroidectomy hypocalcemia by one single iPTH measurement Surgery 136 2004 1236 1241